itching

eczema skin condition
Biotech

GSK posts phase 3 itch data as it closes in on FDA approval

GSK said patients on linerixibat reported reductions in itching that began after two weeks and persisted through the 24-week primary endpoint.
Nick Paul Taylor May 8, 2025 8:50am
Graphic of a dart right on a bullseye sun breaking through the clouds in the background

GSK’s itch prospect hits mark in phase 3 liver disease trial

Nov 19, 2024 8:24am
Deal terminate tear up end deal scrap

Connect uncouples from Pfizer by scrapping eczema pact

Apr 17, 2024 6:38am
Photo of a 100 bill about to be cut with scissors

Itch treater Cara cuts 50% of team to extend runway into 2026

Jan 22, 2024 9:44am
scratch

Breaking the vicious itch-scratch cycle via 'miswired' neurons

Jul 14, 2022 5:08am
Dermatologist

Evommune snags $83M for "Tylenol for itch," three other programs

Sep 9, 2021 7:30am